Zachary Henry, MD
Gastroenterology · Charlottesville, VANPI 1992964134
Payments from drug & device makers
Across 207 payments — averaging $194.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$22K
- Novo Nordisk AS$17K
- Viiv Healthcare Company$558
- Cook Medical LLC$60
- Novo Nordisk$45
- Lilly USA, LLC$14
Across 7 payments — averaging $226.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$2K
What the payments were for
- Food & beverage$677100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 1 | $22,438 |
| Novo Nordisk AS | 171 | $17,209 |
| Viiv Healthcare Company | 30 | $558 |
| Cook Medical LLC | 2 | $60 |
| Novo Nordisk | 2 | $45 |
| Lilly USA, LLC | 1 | $14 |
How this compares
$40,324 in reported general payments places this provider in the 85th percentile of 473 gastroenterology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XifaxanRifaximin | 52 | $140,631 |
| VemlidyTenofovir Alafenamide | 47 | $65,161 |
| Ursodiol | 63 | $16,970 |
| Tacrolimus | 148 | $14,833 |
| Cyclosporine ModifiedCyclosporine, Modified | 54 | $7,537 |
| Mycophenolate Mofetil | 50 | $3,463 |
| ConstuloseLactulose | 31 | $1,655 |
| Lactulose | 32 | $1,579 |
| Entecavir | 42 | $1,573 |
| Pantoprazole Sodium | 82 | $716 |
| Spironolactone | 46 | $676 |
| Amiloride Hcl | 18 | $633 |
| Carvedilol | 78 | $524 |
| Azathioprine | 22 | $426 |
| Omeprazole | 26 | $295 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Charlottesville
- Stephen CaldwellCharlottesville$1.8M
- Anne TuskeyCharlottesville$977K
- Mohammad SiddiquiCharlottesville$728K
- Bryan SauerCharlottesville$540K
- Brian WentworthCharlottesville$383K
- Vanessa ShamiCharlottesville$287K
- Esteban FigueroaCharlottesville$239K
- David PeuraCharlottesville$103K
- Daniel PambiancoCharlottesville$53K
- Larry ClarkLynchburg$8.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.